Eli Lilly plans single-digit billion dollar new German plant -sources

[ad_1] An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File Photo Acquire Licensing Rights BERLIN, Nov…

Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.

[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March…

Novo Nordisk, Eli Lilly rake in cash from weight-loss drugs

[ad_1] Comment on this storyComment Add to your saved stories Save Novo Nordisk and Eli Lilly reported booming sales Thursday from the new generation of diabetes and weight-loss drugs they’ve…

Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook

[ad_1] Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that…

Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity

[ad_1] Revenue in Q3 2023 increased 37%, driven by growth from Mounjaro, Verzenio and Jardiance, as well as $1.42 billion from the sale of rights for the olanzapine portfolio (Zyprexa).…

Exclusive: Lilly hires CordenPharma to make diabetes drug Mounjaro’s active ingredient -source

[ad_1] An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Picture taken March 5, 2021. REUTERS/Mike Segar/File Photo…

Eli Lilly Diabetes, Obesity Head Mike Mason to Retire

[ad_1] The head of Eli Lilly’s burgeoning diabetes and obesity franchise is retiring at the end of the year. Mike Mason is leaving after 34 years with the company. [ad_2]…

Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies

[ad_1] INDIANAPOLIS, Oct. 3, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and POINT Biopharma Global, Inc. (NASDAQ: PNT) today announced a definitive agreement for Lilly to acquire POINT, a radiopharmaceutical company with…

Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug

[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29,…

The Score: Eli Lilly, WeWork, Walt Disney and More Stocks That Defined the Week

[ad_1] Here are some of the major companies whose stocks moved on the week’s news. [ad_2] Source link